(19)
(11) EP 4 815 917 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898404.9

(22) Date of filing: 14.05.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/51(2006.01)
A61K 47/38(2006.01)
A61K 31/00(2006.01)
 A61K 9/127(2025.01)
A61K 9/10(2006.01)
A61K 47/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/658; A61K 9/006; A61K 31/352; A61K 31/05; A61K 47/36; A61K 9/1623; A24B 13/00; A24B 15/16; A23L 33/105; A24B 15/303; A24B 15/30; A24B 15/286
(86) International application number:
PCT/US2024/029339
(87) International publication number:
WO 2025/116961 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 US 202363603072 P

(71) Applicant: J.D.I.P., LLC
Palisade, Colorado 81526 (US)

(72) Inventors:
  • LOUGHMAN, Jesse
    Palisade, Colorado 81526 (US)
  • HUTCHINSON, Tyler
    Palisade, Colorado 81526 (US)

(74) Representative: Slingsby Partners LLP 
1 Kingsway
London WC2B 6AN
London WC2B 6AN (GB)

   


(54) CANNABIS COMPOSITIONS, ORAL PRODUCTS, AND METHODS OF MAKING SAME